SPY327.39-10.83 -3.20%
DIA265.77-8.89 -3.24%
IXIC11,039.74-391.61 -3.43%

Wells Fargo Maintains Equal-Weight on Iovance Biotherapeutics, Raises Price Target to $35

Wells Fargo maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Equal-Weight and raises the price target from $29 to $35.

· 10/15/2020 07:38
Wells Fargo maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Equal-Weight and raises the price target from $29 to $35.